Pharmaceutical testing is a fundamental process in ensuring the safety, efficacy, and quality of pharmaceutical products. It involves a thorough examination of drugs and medicinal substances at different stages of development and production. Stringent testing protocols are in place to meet regulatory standards, ensuring that pharmaceuticals adhere to the highest quality benchmarks.
Analytical testing is a cornerstone of pharmaceutical testing, employing techniques such as chromatography, spectroscopy, and mass spectrometry to evaluate the composition and purity of drug formulations. Stability testing is equally vital, investigating how pharmaceutical products react under diverse conditions over time to ascertain their shelf-life and efficacy.
Quality control measures encompass microbiological testing, where products undergo assessment for the presence of microorganisms that could pose safety risks. Bioavailability and bioequivalence studies play a key role in understanding how the human body absorbs and processes pharmaceuticals.
Pharmaceutical testing is a dynamic field that adapts to emerging technologies and regulatory requirements. Its ongoing evolution is crucial in upholding the integrity and effectiveness of pharmaceutical products, ultimately safeguarding public health.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia